📂 Drugs
Daratumumab/hyaluronidase — Definition
Daratumumab/hyalüronidaz / Daratumumab/hyaluronidase
Daratumumab/hyaluronidase is a combination drug used in the treatment of multipl myeloma. Daratumumab is a monochlonal antibody that allows the destruction of cancer cells by connecting to CD38 protein. Hyaluronidase is a enzyme that breaks hyaluronic acid to facilitate the injection of skin to six tissues. This combination can be given in less time and subcutaneously than intravenous administration.
Frequently Asked Questions
❓ What is Daratumumab/hyalüronidaz?
Daratumumab/hyalüronidaz; daratumumab/hyaluronidase is a combination drug used in the treatment of multipl myeloma. Daratumumab is a monochlonal antibody that allows the destruction of cancer cells by connecting to CD38 protein. Hyaluronidase is a enzyme that breaks hyaluronic acid to facilitate the injection of skin to six tissues. This combination can be given in less time and subcutaneously than intravenous administration.
❓ What is Daratumumab/hyaluronidase in Turkish?
The Turkish equivalent of "Daratumumab/hyaluronidase" is Daratumumab/hyalüronidaz.
❓ Which medical field is Daratumumab/hyalüronidaz related to?
This term belongs to the Drugs category.